vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $78.6M, roughly 1.1× Repay Holdings Corp). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -178.3%, a 201.1% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 0.4%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $23.2M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -1.3%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
FDMT vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $78.6M |
| Net Profit | $19.4M | $-140.1M |
| Gross Margin | — | 74.2% |
| Operating Margin | 17.3% | -182.2% |
| Net Margin | 22.8% | -178.3% |
| Revenue YoY | 8508900.0% | 0.4% |
| Net Profit YoY | 139.1% | -3304.1% |
| EPS (diluted) | $0.43 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $78.6M | ||
| Q3 25 | $90.0K | $77.7M | ||
| Q2 25 | $15.0K | $75.6M | ||
| Q1 25 | $14.0K | $77.3M | ||
| Q4 24 | $1.0K | $78.3M | ||
| Q3 24 | $3.0K | $79.1M | ||
| Q2 24 | $5.0K | $74.9M | ||
| Q1 24 | $28.0K | $80.7M |
| Q4 25 | $19.4M | $-140.1M | ||
| Q3 25 | $-56.9M | $-6.4M | ||
| Q2 25 | $-54.7M | $-102.3M | ||
| Q1 25 | $-48.0M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-43.8M | $3.2M | ||
| Q2 24 | $-35.0M | $-4.1M | ||
| Q1 24 | $-32.4M | $-5.2M |
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
| Q4 25 | 17.3% | -182.2% | ||
| Q3 25 | -67983.3% | -3.9% | ||
| Q2 25 | -396373.3% | -138.7% | ||
| Q1 25 | -383007.1% | -4.7% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | -1704400.0% | -0.9% | ||
| Q2 24 | -849120.0% | -4.6% | ||
| Q1 24 | -136200.0% | -3.1% |
| Q4 25 | 22.8% | -178.3% | ||
| Q3 25 | -63195.6% | -8.3% | ||
| Q2 25 | -364386.7% | -135.2% | ||
| Q1 25 | -342657.1% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | -1461433.3% | 4.1% | ||
| Q2 24 | -699060.0% | -5.4% | ||
| Q1 24 | -115717.9% | -6.5% |
| Q4 25 | $0.43 | $-1.68 | ||
| Q3 25 | $-1.01 | $-0.08 | ||
| Q2 25 | $-0.98 | $-1.15 | ||
| Q1 25 | $-0.86 | $-0.09 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | $-0.79 | $0.03 | ||
| Q2 24 | $-0.63 | $-0.04 | ||
| Q1 24 | $-0.66 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $505.7M | $484.4M |
| Total Assets | $566.7M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $115.7M | ||
| Q3 25 | $305.1M | $95.7M | ||
| Q2 25 | $293.2M | $162.6M | ||
| Q1 25 | $321.4M | $165.5M | ||
| Q4 24 | $424.9M | $189.5M | ||
| Q3 24 | $501.9M | $168.7M | ||
| Q2 24 | $541.9M | $147.1M | ||
| Q1 24 | $525.9M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | $505.7M | $484.4M | ||
| Q3 25 | $369.0M | $616.9M | ||
| Q2 25 | $420.9M | $633.7M | ||
| Q1 25 | $469.7M | $755.7M | ||
| Q4 24 | $510.6M | $761.3M | ||
| Q3 24 | $552.9M | $754.7M | ||
| Q2 24 | $588.3M | $815.4M | ||
| Q1 24 | $600.6M | $813.8M |
| Q4 25 | $566.7M | $1.2B | ||
| Q3 25 | $424.0M | $1.3B | ||
| Q2 25 | $473.6M | $1.4B | ||
| Q1 25 | $515.7M | $1.5B | ||
| Q4 24 | $560.4M | $1.6B | ||
| Q3 24 | $604.0M | $1.6B | ||
| Q2 24 | $620.1M | $1.5B | ||
| Q1 24 | $629.9M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $23.3M |
| Free Cash FlowOCF − Capex | $28.5M | $23.2M |
| FCF MarginFCF / Revenue | 33.5% | 29.6% |
| Capex IntensityCapex / Revenue | 0.1% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $23.3M | ||
| Q3 25 | $-46.5M | $32.2M | ||
| Q2 25 | $-43.4M | $33.1M | ||
| Q1 25 | $-47.8M | $2.5M | ||
| Q4 24 | $-134.6M | $34.3M | ||
| Q3 24 | $-29.4M | $60.1M | ||
| Q2 24 | $-30.2M | $31.0M | ||
| Q1 24 | $-29.1M | $24.8M |
| Q4 25 | $28.5M | $23.2M | ||
| Q3 25 | $-46.6M | $32.1M | ||
| Q2 25 | $-43.4M | $33.0M | ||
| Q1 25 | $-48.4M | $2.4M | ||
| Q4 24 | $-138.4M | $34.0M | ||
| Q3 24 | $-31.2M | $59.8M | ||
| Q2 24 | $-30.6M | $30.5M | ||
| Q1 24 | $-29.8M | $24.7M |
| Q4 25 | 33.5% | 29.6% | ||
| Q3 25 | -51765.6% | 41.3% | ||
| Q2 25 | -289620.0% | 43.6% | ||
| Q1 25 | -345635.7% | 3.0% | ||
| Q4 24 | -13837100.0% | 43.5% | ||
| Q3 24 | -1038966.7% | 75.6% | ||
| Q2 24 | -611840.0% | 40.7% | ||
| Q1 24 | -106421.4% | 30.6% |
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 101.1% | 0.2% | ||
| Q2 25 | 440.0% | 0.1% | ||
| Q1 25 | 4507.1% | 0.2% | ||
| Q4 24 | 378600.0% | 0.3% | ||
| Q3 24 | 59266.7% | 0.3% | ||
| Q2 24 | 6980.0% | 0.6% | ||
| Q1 24 | 2535.7% | 0.1% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
